Werewolf Therapeutics Correlations

HOWL Stock

USD 1.41 0.01 0.71%

The current 90-days correlation between Werewolf Therapeutics and Ikena Oncology is 0.16 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Werewolf Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Werewolf Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Werewolf Therapeutics Correlation With Market

Weak diversification

The correlation between Werewolf Therapeutics and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Werewolf Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Werewolf Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.

Moving together with Werewolf Stock

0.79	RCUS	Arcus Biosciences	Pair Corr
0.72	AVAL	Grupo Aval	Pair Corr
0.75	KB	KB Financial Group Earnings Call This Week	Pair Corr
0.74	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.64	WF	Woori Financial Group Earnings Call This Week	Pair Corr
0.71	CSCO	Cisco Systems	Pair Corr
0.68	IBM	International Business Earnings Call This Week	Pair Corr
0.62	AA	Alcoa Corp	Pair Corr
0.75	MSFT	Microsoft	Pair Corr
0.75	DIS	Walt Disney	Pair Corr
0.64	AXP	American Express	Pair Corr

Moving against Werewolf Stock

0.37

Coca Cola Earnings Call This Week

Pair Corr

Related Correlations Analysis

	EWTX	IKNA	DSGN	XLO	CLYM	FNCH	BMEA
EWTX		0.01	0.62	0.12	-0.06	0.0	0.42	EWTX
IKNA	0.01		0.36	-0.55	0.38	0.0	0.64	IKNA
DSGN	0.62	0.36		-0.04	0.35	0.0	0.44	DSGN
XLO	0.12	-0.55	-0.04		-0.2	0.0	-0.47	XLO
CLYM	-0.06	0.38	0.35	-0.2		0.0	0.32	CLYM
FNCH	0.0	0.0	0.0	0.0	0.0		0.0	FNCH
BMEA	0.42	0.64	0.44	-0.47	0.32	0.0		BMEA
	EWTX	IKNA	DSGN	XLO	CLYM	FNCH	BMEA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BMEA	+ 0.64	IKNA
DSGN	+ 0.62	EWTX
BMEA	+ 0.44	DSGN
BMEA	+ 0.42	EWTX
CLYM	+ 0.38	IKNA
DSGN	+ 0.36	IKNA

High negative correlations

XLO	- 0.55	IKNA
BMEA	- 0.47	XLO
CLYM	- 0.2	XLO
CLYM	- 0.06	EWTX
XLO	- 0.04	DSGN
BMEA	- 0.0	FNCH

Risk-Adjusted Indicators

There is a big difference between Werewolf Stock performing well and Werewolf Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Werewolf Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EWTX	2.40	0.06	0.02	0.20	3.36	(2.39)	5.66	(3.95)	22.67
IKNA	2.51	0.07	0.01	0.22	2.97	(2.94)	5.47	(3.94)	18.39
DSGN	3.94	0.23	0.06	0.28	5.04	(4.04)	8.13	(8.26)	27.45
XLO	4.53	0.50	0.04	(0.99)	7.27	(6.43)	7.50	(6.67)	92.11
CLYM	3.31	0.09	0.04	0.19	3.48	(4.07)	7.50	(6.35)	20.13
FNCH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BMEA	6.85	0.32	0.07	0.23	8.58	(7.81)	11.65	(10.43)	94.78

Werewolf Therapeutics Corporate Management

Randi MD	Chief Officer	Profile
Timothy CPA	Treasurer CFO	Profile
Cynthia SeidelDugan	Chief Officer	Profile
Ellen MBA	Chief Officer	Profile
Daniel Hicklin	CEO, Founder	Profile
William Winston	Senior Research	Profile
Chulani Karunatilake	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC